comparemela.com

Latest Breaking News On - Quarter for fusion pharmaceuticals - Page 1 : comparemela.com

Avidity Partners Management LP Has $62.47 Million Stock Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Avidity Partners Management LP lifted its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,500,328 shares of the company’s stock after buying an additional 718,478 shares during the quarter. Fusion Pharmaceuticals […]

China
Canada
United-states
New-york
William-blair
Quarter-for-fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Fusion-pharmaceuticals-stock-performance
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
Exchange-commission
York-state-common-retirement-fund

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Yarbrough Capital LLC Makes New $739,000 Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
William-blair
Fusion-pharmaceuticals-profile
Exchange-commission
Citadel-advisors
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Schonfeld-strategic-advisors
Renaissance-technologies
Jefferies-financial-group

Forefront Analytics LLC Has $88,000 Stock Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Forefront Analytics LLC grew its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 67.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,685 shares of the company’s stock after buying an additional 13,610 shares during the period. Forefront Analytics LLC’s holdings in […]

Canada
United-states
William-blair
Raymond-james
Forefront-analytics
Eagle-health-investments
Nasdaq
Royal-bank
Sphera-funds-management
Perceptive-advisors
Fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily

13,084 Shares in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Bought by Virtu Financial LLC

Virtu Financial LLC purchased a new position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 13,084 shares of the company’s stock, valued at approximately $49,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in FUSN. Federated Hermes Inc. increased […]

United-states
Canada
Raymond-james
Millennium-management
Fusion-pharmaceuticals
Nasdaq
Fusion-pharmaceuticals-inc
Virtu-financial
Quarter-for-fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily
Fusion-pharmaceuticals-trading-down
Renaissance-technologies

Braidwell LP Makes New $6.30 Million Investment in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Braidwell LP bought a new stake in shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) in the fourth quarter, Holdings Channel reports. The fund bought 2,000,000 shares of the company’s stock, valued at approximately $6,300,000. A number of other institutional investors and hedge funds have also recently modified their holdings of FUSN. Renaissance Technologies […]

United-states
Canada
News-ratings-for-fusion-pharmaceuticals-daily
Nasdaq
Quarter-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-trading-down
Holdings-channel
Prudential-financial-inc
Fusion-pharmaceuticals
Fusion-pharmaceuticals-inc
Renaissance-technologies

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.